The expression of IFN significantly enhanced the cytotoxicity of 5-FU, GEM, and CDDP in pancreatic cancer cell lines and sensitized radiotherapy in in vivo models, confirming the role of IFN as a chemo- and radiotherapy sensitizer. The gene discussed is IFNA1; the disease is pancreatic neoplasm.